Literature DB >> 27460989

Binding of the cytoplasmic domain of CD28 to the plasma membrane inhibits Lck recruitment and signaling.

Jessica Dobbins1, Etienne Gagnon2, Jernej Godec3, Jason Pyrdol2, Dario A A Vignali4, Arlene H Sharpe3, Kai W Wucherpfennig5.   

Abstract

The T cell costimulatory receptor CD28 is required for the full activation of naïve T cells and for the development and maintenance of Foxp3(+) regulatory T (Treg) cells. We showed that the cytoplasmic domain of CD28 was bound to the plasma membrane in resting cells and that ligand binding to CD28 resulted in its release. Membrane binding by the CD28 cytoplasmic domain required two clusters of basic amino acid residues, which interacted with the negatively charged inner leaflet of the plasma membrane. These same clusters of basic residues also served as interaction sites for Lck, a Src family kinase critical for CD28 function. This signaling complex was further stabilized by the Lck-mediated phosphorylation of CD28 Tyr(207) and the subsequent binding of the Src homology 2 (SH2) domain of Lck to this phosphorylated tyrosine. Mutation of the basic clusters in the CD28 cytoplasmic domain reduced the recruitment to the CD28-Lck complex of protein kinase Cθ (PKCθ), which serves as a key effector kinase in the CD28 signaling pathway. Consequently, mutation of either a basic cluster or Tyr(207) impaired CD28 function in mice as shown by the reduced thymic differentiation of FoxP3(+) Treg cells. On the basis of these results, we propose a previously undescribed model for the initiation of CD28 signaling.
Copyright © 2016, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27460989      PMCID: PMC5929992          DOI: 10.1126/scisignal.aaf0626

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  53 in total

Review 1.  Positive and negative regulation of T-cell activation through kinases and phosphatases.

Authors:  Tomas Mustelin; Kjetil Taskén
Journal:  Biochem J       Date:  2003-04-01       Impact factor: 3.857

Review 2.  CD28-mediated co-stimulation: a quantitative support for TCR signalling.

Authors:  Oreste Acuto; Frédérique Michel
Journal:  Nat Rev Immunol       Date:  2003-12       Impact factor: 53.106

3.  CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones.

Authors:  F A Harding; J G McArthur; J A Gross; D H Raulet; J P Allison
Journal:  Nature       Date:  1992-04-16       Impact factor: 49.962

4.  CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2.

Authors:  Xuguang Tai; Michelle Cowan; Lionel Feigenbaum; Alfred Singer
Journal:  Nat Immunol       Date:  2005-01-09       Impact factor: 25.606

5.  Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules.

Authors:  Z Shen; G Reznikoff; G Dranoff; K L Rock
Journal:  J Immunol       Date:  1997-03-15       Impact factor: 5.422

6.  Translational activation of the lck proto-oncogene.

Authors:  J D Marth; R W Overell; K E Meier; E G Krebs; R M Perlmutter
Journal:  Nature       Date:  1988-03-10       Impact factor: 49.962

7.  CD28 promotes CD4+ T cell clonal expansion during infection independently of its YMNM and PYAP motifs.

Authors:  Antonio J Pagán; Marion Pepper; H Hamlet Chu; Jonathan M Green; Marc K Jenkins
Journal:  J Immunol       Date:  2012-08-15       Impact factor: 5.422

8.  Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation.

Authors:  G J Freeman; J G Gribben; V A Boussiotis; J W Ng; V A Restivo; L A Lombard; G S Gray; L M Nadler
Journal:  Science       Date:  1993-11-05       Impact factor: 47.728

9.  Targeted knock-in mice expressing mutations of CD28 reveal an essential pathway for costimulation.

Authors:  Lindzy F Dodson; Jonathan S Boomer; Christine M Deppong; Dulari D Shah; Julia Sim; Traci L Bricker; John H Russell; Jonathan M Green
Journal:  Mol Cell Biol       Date:  2009-04-27       Impact factor: 4.272

10.  Activation of calcium and phospholipid-dependent protein kinase by diacylglycerol, its possible relation to phosphatidylinositol turnover.

Authors:  A Kishimoto; Y Takai; T Mori; U Kikkawa; Y Nishizuka
Journal:  J Biol Chem       Date:  1980-03-25       Impact factor: 5.157

View more
  23 in total

1.  Ionic CD3-Lck interaction regulates the initiation of T-cell receptor signaling.

Authors:  Lunyi Li; Xingdong Guo; Xiaoshan Shi; Changting Li; Wei Wu; Chengsong Yan; Haopeng Wang; Hua Li; Chenqi Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-28       Impact factor: 11.205

2.  Critical role of post-transcriptional regulation for IFN-γ in tumor-infiltrating T cells.

Authors:  Fiamma Salerno; Aurelie Guislain; Julian J Freen-Van Heeren; Benoit P Nicolet; Howard A Young; Monika C Wolkers
Journal:  Oncoimmunology       Date:  2018-10-22       Impact factor: 8.110

3.  Phosphoproteomic analysis of chimeric antigen receptor signaling reveals kinetic and quantitative differences that affect cell function.

Authors:  Alexander I Salter; Richard G Ivey; Jacob J Kennedy; Valentin Voillet; Anusha Rajan; Eva J Alderman; Uliana J Voytovich; Chenwei Lin; Daniel Sommermeyer; Lingfeng Liu; Jeffrey R Whiteaker; Raphael Gottardo; Amanda G Paulovich; Stanley R Riddell
Journal:  Sci Signal       Date:  2018-08-21       Impact factor: 8.192

4.  THEMIS-SHP1 Recruitment by 4-1BB Tunes LCK-Mediated Priming of Chimeric Antigen Receptor-Redirected T Cells.

Authors:  Chuang Sun; Peishun Shou; Hongwei Du; Koichi Hirabayashi; Yuhui Chen; Laura E Herring; Sarah Ahn; Yang Xu; Kyogo Suzuki; Guangming Li; Ourania Tsahouridis; Lishan Su; Barbara Savoldo; Gianpietro Dotti
Journal:  Cancer Cell       Date:  2020-01-30       Impact factor: 31.743

Review 5.  Co-stimulatory and co-inhibitory pathways in cancer immunotherapy.

Authors:  Rachel E O'Neill; Xuefang Cao
Journal:  Adv Cancer Res       Date:  2019-04-17       Impact factor: 6.242

6.  Conformational States Control Lck Switching between Free and Confined Diffusion Modes in T Cells.

Authors:  Geva Hilzenrat; Elvis Pandžić; Zhengmin Yang; Daniel J Nieves; Jesse Goyette; Jérémie Rossy; Yuanqing Ma; Katharina Gaus
Journal:  Biophys J       Date:  2020-02-11       Impact factor: 4.033

Review 7.  CARs: Synthetic Immunoreceptors for Cancer Therapy and Beyond.

Authors:  ZeNan L Chang; Yvonne Y Chen
Journal:  Trends Mol Med       Date:  2017-04-13       Impact factor: 11.951

8.  Identification of Biomarkers Related to Regulatory T Cell Infiltration in Oral Squamous Cell Carcinoma Based on Integrated Bioinformatics Analysis.

Authors:  Chao Wang; Zhihong Chen; Xueming Yang; Wei Zhang; Junbo Zhou; Hongchuang Zhang; Xu Ding; Jinhai Ye; Heming Wu; Yunong Wu; Yang Zheng; Xiaomeng Song
Journal:  Int J Gen Med       Date:  2022-03-02

Review 9.  Introducing Membrane Charge and Membrane Potential to T Cell Signaling.

Authors:  Yuanqing Ma; Kate Poole; Jesse Goyette; Katharina Gaus
Journal:  Front Immunol       Date:  2017-11-09       Impact factor: 7.561

10.  Determination of the molecular reach of the protein tyrosine phosphatase SHP-1.

Authors:  Lara Clemens; Mikhail Kutuzov; Kristina Viktoria Bayer; Jesse Goyette; Jun Allard; Omer Dushek
Journal:  Biophys J       Date:  2021-03-27       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.